(Q50736607)

18 March 2018

title

[Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study] (English)

1 reference

18 March 2018

chronic obstructive pulmonary disease

main subject

1 reference

Masa JF

1

1 reference

18 March 2018

Sobradillo V

2

1 reference

18 March 2018

Villasante C

3

1 reference

18 March 2018

Jiménez-Ruiz CA

4

1 reference

18 March 2018

Fernández-Fau L

5

1 reference

18 March 2018

Viejo JL

6

1 reference

18 March 2018

Miravitlles M

7

1 reference

18 March 2018

publication date

1 February 2004

1 reference

18 March 2018

Archivos de Bronconeumologia

published in

1 reference

18 March 2018

volume

40

1 reference

18 March 2018

issue

2

1 reference

18 March 2018

page(s)

72-79

1 reference

18 March 2018

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Costs of chronic bronchitis and COPD: a 1-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Costs of COPD in Sweden according to disease severity.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Capitation, managed care, and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Pharmacoeconomic evaluation of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

[Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): recruitment and field work]

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Standardization of spirometry--1987 update. Statement of the American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

The effect of diabetes mellitus on the outcome of patients with chronic obstructive pulmonary disease exacerbated due to respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

The cost of chronic obstructive pulmonary disease in Spain: options for optimizing resources

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

[Guidelines on the diagnosis and treatment of chronic obstructive lung disease. The SEPAR Working Group. The Spanish Society of Pneumology and Thoracic Surgery]

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

The costs of treating COPD in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2806%2960198-5

7 January 2021

10.1016/S1579-2129(06)60198-5

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018